Medicon Hellas S.A. (ATH:MEDIC)
Greece · Delayed Price · Currency is EUR 2.900
+0.020 (0.69%)
Last updated: Oct 9, 2026, 4:46 PM EET
Medicon Hellas Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13 | 11 | 10 | 15 | 16 | 22 | |
Market Cap Growth | 18.37% | 17.13% | -35.13% | -10.00% | -24.18% | 156.84% |
Enterprise Value | 16 | 12 | 11 | 17 | 19 | 29 |
Last Close Price | 2.88 | 2.40 | 1.94 | 2.92 | 3.12 | 4.11 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 5.17 | 6.45 | 6.99 | 11.14 | 6.46 | 7.09 |
PS Ratio | 0.68 | 0.62 | 0.53 | 0.81 | 0.79 | 1.00 |
PB Ratio | 0.60 | 0.57 | 0.51 | 0.83 | 0.93 | 1.44 |
P/TBV Ratio | 0.61 | 0.57 | 0.52 | 0.86 | 0.97 | 1.51 |
P/FCF Ratio | 3.36 | 3.84 | 9.59 | - | 19.45 | 5.09 |
P/OCF Ratio | 2.22 | 2.54 | 4.77 | 16.76 | 13.10 | 4.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.84 | 0.66 | 0.61 | 0.93 | 0.91 | 1.33 |
EV/EBITDA Ratio | 3.50 | 3.49 | 3.78 | 5.48 | 3.71 | 4.66 |
EV/EBIT Ratio | 5.21 | 5.36 | 6.71 | 9.49 | 4.92 | 5.73 |
EV/FCF Ratio | 4.14 | 4.07 | 11.12 | - | 22.49 | 6.75 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.41 | 0.47 | 0.51 | 0.60 | 0.63 | 0.81 |
Debt / EBITDA Ratio | 1.96 | 2.49 | 2.79 | 3.07 | 2.01 | 1.82 |
Debt / FCF Ratio | 2.32 | 3.18 | 9.48 | - | 13.12 | 2.86 |
Net Debt / Equity Ratio | 0.12 | -0.07 | 0.05 | 0.12 | 0.05 | 0.12 |
Net Debt / EBITDA Ratio | 0.64 | -0.42 | 0.32 | 0.71 | 0.16 | 0.29 |
Net Debt / FCF Ratio | 0.70 | -0.49 | 0.93 | -3.05 | 0.97 | 0.41 |
Asset Turnover | 0.56 | 0.56 | 0.57 | 0.57 | 0.66 | 0.72 |
Inventory Turnover | 1.45 | 1.52 | 1.70 | 1.68 | 1.97 | 1.93 |
Quick Ratio | 3.52 | 4.31 | 4.65 | 4.35 | 5.20 | 3.81 |
Current Ratio | 5.76 | 5.19 | 5.49 | 5.24 | 6.08 | 4.45 |
Return on Equity (ROE) | 12.43% | 9.23% | 6.78% | 6.96% | 16.64% | 24.12% |
Return on Assets (ROA) | 5.71% | 4.30% | 3.25% | 3.49% | 7.63% | 10.44% |
Return on Invested Capital (ROIC) | 11.26% | 9.97% | 7.28% | 7.62% | 16.23% | 19.47% |
Return on Capital Employed (ROCE) | 10.20% | 7.80% | 6.00% | 6.40% | 13.70% | 18.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 19.35% | 15.49% | 14.31% | 8.98% | 15.49% | 14.10% |
FCF Yield | 29.79% | 26.02% | 10.43% | -4.87% | 5.14% | 19.64% |
Dividend Yield | 4.48% | - | 6.71% | 2.05% | 4.91% | - |
Payout Ratio | 23.32% | 33.16% | 19.41% | 84.30% | 4.20% | 3.76% |
Total Shareholder Return | 4.52% | - | 6.71% | 2.05% | 4.91% | - |